Isonics' SenseIt Subsidiary Appoints Fred L. Marion as Chief Operating Officer and Marshall J. Cohen Ph.D. as Senior Technical Advisor.

GOLDEN, Colo. -- Isonics Corporation (NASDAQ: ISON), a provider of innovative solutions for the homeland security and semiconductor markets, announced today that its 90%-owned subsidiary, SenseIt Corp (SenseIt) has hired Fred L. Marion as its Chief Operating Officer and Marshall J. Cohen Ph.D. as a Senior Technical Advisor and a member of SenseIt's Advisory Board. These accomplished executives, with more than forty years of combined experience in the homeland security and defense industries, will play significant roles as SenseIt works with its development partner (as described in its press release dated December 6, 2005) to develop, produce and market its first night vision thermal sensor prototype units this Fall.

Mr. Marion's background includes significant expertise in both U.S. and international joint ventures. Dr. Cohen is the author of more than 40 scientific publications and over 100 technical papers. He holds six U.S. patents and has directed over 50 government-supported R&D programs.

"I am pleased that we were able to attract such experienced and accomplished executives to SenseIt as we continue to develop several exciting security technologies (through our relationship with our development partner)," said Christopher Toffales, Chairman of Isonics Corporation and CEO and 10% owner of SenseIt. "Each of them has extensive experience in developing innovative security and defense technologies. I look forward to working with them to commercialize our innovative technologies."

Mr. Marion was the President of DRS Technologies Inc., Surveillance and Reconnaissance Group (SRG) from April 2004 to October 2006. While there, he led the development of the company's Reconnaissance, Surveillance and Target Acquisition, Training and Control Systems and Test and Energy Management businesses. Upon his departure, SRG had revenue of approximately $800 million and 2,000 employees throughout North America. Mr. Marion joined DRS in January 2000 as President of the Electro- Optical Systems Group (ESOG). He led the Vice Presidents and General Managers of three divisions, where revenue increased (through acquisitions and internal growth) from $140 million in January 2000 to over $400 million in 2004.

Mr. Marion played an integral role in new business wins on projects that included Driver's Vision Enhancer, Thermal Weapon Sight, Tactical Range Thermal Imager, Mast Mounted Sight, and Future Combat System gimbaled sight systems, resulting in over $2.3 Billion in revenue to SRG.

Before joining DRS he was Vice President, Special Projects, reporting to the President of the Lockheed Martin Electronics Sector. Prior to that, he was Vice President, Fire Control Systems for Lockheed Martin Electronics and Missiles, where he was responsible for operations, business planning and contract performance and overall profit and loss for such programs as Low Altitude Navigation and Targeting Infrared for Night for U.S. Air Force F-16C/D and F-15E and U.S. Navy F-14 aircraft, U.S. Army Apache Target-Acquisition Designation Sight and Pilot Night-Vision Sensor, Apache Longbow Fire Control Radar, Comanche Electro-Optical Sensor System, Joint Strike Fighter Electro-Optical Fire Control and Tactical Sensor Suite.

Mr. Marion held senior positions at Martin Marietta (acquired by Lockheed Martin Missiles and Electronics) including Vice President and Program Director of Pershing II from 1983 through 1985, Vice-President for Air Defense Systems from 1986 to 1992, Vice President for Missile Systems from 1992 to 1994 and Vice President for Business Development and Advanced Systems from 1994 to September 1996.

Mr. Marion received his bachelor's degree in Aerospace Engineering from the Georgia Institute of Technology and has completed class work for a master's degree in Aerospace Engineering at the University of Florida. He received the Distinguished Engineer Award from Georgia Tech in 1996.

Marshall J. Cohen, Ph.D. recently retired as Vice President and General Manager of SUI Goodrich Corporation (SUI). SUI is a developer and manufacturer of shortwave and near infrared imaging devices and cameras and of optoelectronic devices for fiber optic communications. Its cutting edge camera technology enhances detection capabilities and providing reliable, high performance products used for a variety of critical military, national security, telecommunications and industrial applications such as covert surveillance, machine vision, night vision, health and safety protocols, historical art inspection and many others.

Dr. Cohen co-founded SUI in 1992. He has since led the development of InGaAs linear focal plane arrays and the first commercial indium gallium arsenide (InGaAs) two-dimensional focal plane arrays and cameras.

Prior to joining SUI, Dr. Cohen worked at EG&G Princeton Applied Research in Princeton, New Jersey as a business element manager for their Optical Multi-Channel Analyzer product line. In this role, he had direct responsibility for R&D, manufacturing engineering, marketing and sales.

In 1986, he was named director of research at Applied Solar Energy Corporation in City of Industry, California. He directed programs which led to the development of high efficiency GaAs-on-germanium solar cells and the use of large area growth reactors to produce high conversion efficiency AlGaAs quantum-well laser diodes.

He is also an active committee chairman for Electrical and Electronics Engineers & Laser & Electro-Optics Society.

He received a B.S. in physics (cum laude) from the University of Michigan in 1971 and attended the University of Pennsylvania from 1971 to 1975 where he was awarded a Ph.D. in solid state physics.

About Isonics Corporation

Isonics Corporation has three business divisions: (1) Homeland Security and Defense (2) Semiconductor Products and Services, and (3) Life Sciences (which is currently in the process of being divested). Isonics is a world leader in isotopically engineered materials and through its semiconductor division, it provides 300-millimeter products and services, wafer thinning and silicon-on-insulator wafers, for the semiconductor industry. Isonics' Life Sciences division markets and sells isotopes to the health care industry for the imaging and treatment of cancer. Additional information may be obtained at the Company's Web site at www.isonics.com.

Cautionary Statement

Except for historical information contained herein, this document contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve estimates, assumptions, known and unknown risks and uncertainties that may cause the Company's actual results or outcomes to be materially different from those anticipated and discussed herein. Further, the Company operates in industries where securities values may be volatile and may be influenced by regulatory and other factors beyond the Company's control. Other important factors that the Company believes might cause such differences are discussed in the risk factors detailed in the Company's 10-KSB for the year ended April 30, 2006 and reports subsequently filed with the Securities and Exchange Commission, which include the Company's historical cash flow difficulties, dependence on significant customers, and rapid development of technology, among other risks. In assessing forward-looking statements contained herein, readers are urged to carefully read all cautionary statements contained in these filings with the Securities and Exchange Commission.